Investment-grade corporate bonds are the thing people buy so they can stop thinking about their portfolio. That era has just been quietly cancelled.
The latest batch of listings contains four leveraged bond notes, two of which point in opposite directions, and six leveraged single-stock funds spread across two issuers that appear to be working from the same shortlist.
Leveraged bond products have historically confined themselves to Treasuries, where at least the volatility is a matter of public record and the duration is the whole point. Investment-grade corporate credit has been left alone, largely because tripling the daily move of an asset class designed not to move felt like an odd use of everyone's time.
That reluctance is over. There is now a 3x long and a 3x short note on the same investment-grade corporate bond exposure, launched together, so that traders can express a directional view on credit spreads with the kind of urgency previously reserved for meme stocks. Investment-grade credit is a market where a bad day is measured in fractions of a percent, which means the leverage is doing something actually new here: it is manufacturing volatility that the underlying asset class has spent its entire existence trying not to have.
I keep thinking about the pension-fund risk committee that spent a decade explaining why corporate bonds are the calm part of the portfolio. Somewhere, one of them is reading a pricing supplement and reaching for a drink.
The high-yield versions arrived in the same batch, also in both directions. Inverse high-yield has existed for years, but it has always stopped politely at one time. Tripling it is a different proposition, because high-yield does its real damage in short, brutal episodes where liquidity evaporates and the ETF trades away from the bonds underneath it. A daily-resetting 3x wrapper on that is not a hedge. It is a bet on the timing of a specific kind of accident.
What I admire, and I do mean admire, is the symmetry. Long and short, investment-grade and high-yield, all four launched at once. No house view, no editorial position, just a complete set of tools for whichever way the credit cycle decides to break. If credit does eventually go wrong, someone will be able to say the market was fully equipped.
Here is the detail that made me sit up. Everspin Technologies and MaxLinear signed an agreement to validate Everspin's memory alongside MaxLinear's acceleration platform for server workloads. Two companies, one partnership. In the same batch of listings, two different issuers have each launched a 2x daily fund on one side of it.
Both underlyings have earned the attention, in fairness. Everspin has roughly tripled off its lows on the back of a defence subcontract and the AI server memory story, having spent most of its corporate life as the company whose memory technology was perpetually about to matter. MaxLinear's infrastructure business is now its largest revenue line and the stock has been repriced accordingly, with analysts doubling price targets and then doubling them again.
So we have leveraged exposure to a commercial partnership, sliced by counterparty, wrapped separately, listed simultaneously. Nobody planned this. That is what makes it wonderful.
United Microelectronics is a mature-node foundry. It makes the unglamorous chips at 28 nanometres and above that go into cars, industrial kit and communications gear, on long-term contracts, with none of the leading-edge drama. It is the least fashionable business model in semiconductors, and the shares have more than doubled.
That is the thing about this cycle. The AI trade has spread so far down the supply chain that even the company whose pitch is "we do the old nodes reliably" has become a momentum stock, and momentum stocks now get a leverage button by default. UMC has also told customers to expect wafer price increases, which is what a boring business looks like when demand has genuinely turned.
Alongside it, the same issuer listed a 2x fund on SiTime (SITX, Cboe), a precision timing company trading in the hundreds of dollars per share on a revenue multiple that assumes the AI build-out proceeds without interruption. Doubling the daily move of that is a decision, and I hope everyone taking it has read the second half of the prospectus.
Lumentum makes the optics that move data around AI clusters, and there is already a 2x daily fund on it from a rival issuer that has been trading for months. There is a third version sitting in a registration statement from a third issuer. This new listing means the market for doubling Lumentum's daily move is about to become truly competitive.
There is something almost touching about it. Single stock leverage started as a way to offer exposure nobody else had. It has now matured into a business where issuers race each other to the same underlying, and the differentiator is not the idea but the ticker. Photonics, having spent years as a specialist corner of the optical components industry, is now a category with duplicate leveraged wrappers and a naming convention problem.